Krensavage Asset Management as of March 31, 2017
Portfolio Holdings for Krensavage Asset Management
Krensavage Asset Management holds 15 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bioverativ | 13.1 | $41M | 746k | 54.46 | |
| Gilead Sciences (GILD) | 11.8 | $37M | 537k | 67.92 | |
| Enanta Pharmaceuticals (ENTA) | 10.9 | $34M | 1.1M | 30.80 | |
| United Therapeutics Corporation (UTHR) | 10.2 | $32M | 235k | 135.38 | |
| Sucampo Pharmaceuticals | 9.9 | $31M | 2.8M | 11.00 | |
| Orthofix International Nv Com Stk | 8.6 | $27M | 697k | 38.15 | |
| Merck & Co (MRK) | 7.9 | $25M | 385k | 63.54 | |
| Halyard Health | 7.2 | $22M | 585k | 38.09 | |
| RTI Biologics | 5.7 | $18M | 4.4M | 4.00 | |
| CONMED Corporation (CNMD) | 5.1 | $16M | 356k | 44.41 | |
| Invacare Corporation | 4.4 | $14M | 1.2M | 11.90 | |
| Amgen (AMGN) | 3.6 | $11M | 68k | 164.07 | |
| Aviragen Therapeutics | 0.6 | $1.8M | 2.8M | 0.65 | |
| Digirad Corporation | 0.6 | $1.8M | 334k | 5.30 | |
| Juniper Pharmaceuticals Incorporated | 0.4 | $1.2M | 243k | 4.75 |
